ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC16147-500μg |
|
119911-68-1 |
CGRP 8-37 (human)
|
0 | C139H230N44O38 | |
GC16146-10mM (in 1mL DMSO) |
|
1072833-77-2 |
MLN2238
|
0 | C14H19BCl2N2O4 | |
GC16146-100mg |
|
1072833-77-2 |
MLN2238
|
0 | C14H19BCl2N2O4 | |
GC16146-50mg |
|
1072833-77-2 |
MLN2238
|
0 | C14H19BCl2N2O4 | |
GC16146-10mg |
|
1072833-77-2 |
MLN2238
|
0 | C14H19BCl2N2O4 | |
GC16146-5mg |
|
1072833-77-2 |
MLN2238
|
0 | C14H19BCl2N2O4 | |
GC16145-10mM (in 1mL DMSO) |
|
1245537-68-1 |
NVP-BGT226
|
0 | C28H25F3N6O2.C4H4O4 | |
GC16145-10mg |
|
1245537-68-1 |
NVP-BGT226
|
0 | C28H25F3N6O2.C4H4O4 | |
GC16145-50mg |
|
1245537-68-1 |
NVP-BGT226
|
0 | C28H25F3N6O2.C4H4O4 | |
GC16145-5mg |
|
1245537-68-1 |
NVP-BGT226
|
0 | C28H25F3N6O2.C4H4O4 | |
GC16144-10mM (in 1mL DMSO) |
|
73029-73-9 |
CyPPA
|
0 | C16H23N5 | |
GC16144-50mg |
|
73029-73-9 |
CyPPA
|
0 | C16H23N5 | |
GC16144-10mg |
|
73029-73-9 |
CyPPA
|
0 | C16H23N5 | |
GC16143-25mg |
|
230615-23-3 |
Varenicline Hydrochloride
|
0 | C13H14ClN3 | |
GC16143-5mg |
|
230615-23-3 |
Varenicline Hydrochloride
|
0 | C13H14ClN3 | |
GC16142-10mM (in 1mL DMSO) |
|
99614-02-5 |
Ondansetron
|
0 | C18H19N3O | |
GC16142-50mg |
|
99614-02-5 |
Ondansetron
|
0 | C18H19N3O | |
GC16142-10mg |
|
99614-02-5 |
Ondansetron
|
0 | C18H19N3O | |
GC16141-1mg |
|
27848-84-6 |
Nicergoline
|
0 | C24H26BrN3O3 | |
GC16139-100mg |
|
— |
(R,S)-Anatabine (tartrate)
|
0 | C10H12O2 • C4H6O6 | |